Malaysia Health Supplement Market Forecasted to Grow at a CAGR of 7% by 2019: Radiant Insights

Overview of the health supplement market in Malaysia Technavio's research analyst predicts the health supplement market in Malaysia to grow at a CAGR of 7% during the forecast period. The rise in the aging population in Malaysia is the key driver for the market growth of this region. Products that prevent age-related disorders, such as those linked to the digestive system, and ones that help maintain blood sugar levels, are in high demand among this age group.

The growing demand for probiotic products is also expected to contribute to the market growth in Malaysia. These products are primarily used as a substitute for growth promoters and antibiotics across the globe. For instance, companies such as Yakult Honsha and Chr. Hansen, have developed patented strains of microorganisms (probiotics) claiming to have particular health advantages.

View Summary of This Report @ http://www.radiantinsights.com/research/health-supplement-market-in-malaysia-2015-2019

Segmentation by product and analysis of the health supplement market in Malaysia • Vitamins and dietary supplements
• Weight management products
• Herbal and traditional products

The vitamins and dietary supplements segment led the market with a market share of around 49% during 2014 and is expected to lead the market until the end of 2019. The rise in the aging population and the awareness of benefits from these supplements are the key drivers for the growth of this segment.

Competitive landscape and key vendors
The health supplement market in Malaysia is diversified by the presence of international and regional vendors, competing on the basis of quality and pricing, and market reach and financial resources. The report predicts the competitive environment to intensify further during the forecast period due to product/service extensions, product innovations, and mergers. International players are anticipated to grow inorganically by acquiring regional or local players.

Browse More Categories @ http://www.radiantinsights.com/catalogs

Hepatitis C Market Analysis and Outlook, Pipeline Review, H1 2016 by Radiant Insights

Summary
Global Markets Direct's, 'Hepatitis C - Pipeline Review, H1 2016', provides an overview of the Hepatitis C pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects.

Read Complete Report With TOC @ http://www.radiantinsights.com/research/hepatitis-c-pipeline-review-h1-2016

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Browse More Categories @ http://www.radiantinsights.com/catalogs

About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA

Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: sales@radiantinsights.com
Visit our Blog: http://chemicalsandmaterialsri.blogspot.com/

H1N1 Infection Market Symptoms, Treatment, Causes, Pipeline Review, H1 2016: Radiant Insights

Summary
Global Markets Direct's, 'H1N1 Infection - Pipeline Review, H1 2016', provides an overview of the H1N1 Infection pipeline landscape.

The report provides comprehensive information on the therapeutics under development for H1N1 Infection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for H1N1 Infection and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Browse More Categories @ http://www.radiantinsights.com/catalogs

About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA

Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: sales@radiantinsights.com
Visit our Blog: http://chemicalsandmaterialsri.blogspot.com/

Chronic Obstructive Pulmonary Disease (COPD) Market Size, Symptoms, Pipeline Review, H1 2016: Radiant Insights

Summary
Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Browse More Categories @ http://www.radiantinsights.com/catalogs

Chronic Kidney Disease (Chronic Renal Failure) Market Treatment, Analysis and Outlook, Pipeline Review, H1 2016: Radiant Insights

Summary
Global Markets Direct's, 'Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016', provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Kidney Disease (Chronic Renal Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects.

Read Complete Report With TOC @ http://www.radiantinsights.com/research/chronic-kidney-disease-chronic-renal-failure-pipeline-review-h1-2016

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Browse More Categories @ http://www.radiantinsights.com/catalogs

Acinetobacter Infections Market Size, Analysis and Outlook, Pipeline Review, H1 2016: Radiant Insights

Summary
Global Markets Direct's, 'Acinetobacter Infections - Pipeline Review, H1 2016', provides an overview of the Acinetobacter Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acinetobacter Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acinetobacter Infections and features dormant and discontinued projects.

Read Complete Report With TOC @ http://www.radiantinsights.com/research/acinetobacter-infections-pipeline-review-h1-2016

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Browse More Categories @ http://www.radiantinsights.com/catalogs

About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA

Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: sales@radiantinsights.com

Visit our Blog: http://chemicalsandmaterialsri.blogspot.com/

North America Animal Health Market to Grow at a CAGR of 3.75% by 2019: Radiant Insights

About animal health
Animal healthcare involves guarding, preserving, and preventing diseases in animals, and providing necessary veterinary services to enhance their quality of life, increase their lifespan, and increase their yield. Animal healthcare includes pharmaceuticals, feed additives, and biologicals. Animal pharmaceuticals include parasiticides, anti-infectives, tablets, and other pharmaceuticals. Animal medicinal feed additives improve the quality of food for the animal, thereby improving the health of the animal. Animal biologicals include vaccines, immunostimulants, allergens, bacterins, antibodies, antitoxins, diagnostics, toxoids, and antigenic and immunizing components of microorganisms. These products can be natural or synthetic in origin.

Technavio's analysts forecast the animal health market in North America to grow at a CAGR of 3.75% over the period 2014-2019.

Covered in this report
The report covers the current scenario and growth prospects of the animal health market in North America for the period of 2015-2019. To calculate the market size, the report considers revenue generated through sales of various veterinary healthcare products, including:
Biologicals
Medicinal feed additives
Pharmaceuticals

Technavio's report, Animal Health Market in North America 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America; it also covers the landscape of the animal health market in North America and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market.

Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports